CENTENE CORPORATION CNC Cash Flow

Centene corporation (CNC)

CashFlow / Quarterly

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11	Mar'11	Dec'10	Sep'10	Jun'10	Mar'10
Cash flows from operating activities:
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest
46,000	202,000	96,000	492,000	519,000	241,000	16,000	299,000	338,000	223,000	201,000	252,000	132,000	259,000	148,000	169,000	-15,000	111,000	94,000	88,000	64,000	105,000	78,000	49,000	32,000	55,164	48,914	39,011	22,911	4,934	295	-38,832	22,603	29,264	28,213	28,063	22,823	26,319	23,200	24,502	24,250
Adjustments to reconcile net earnings to net cash provided by operating activities
Depreciation and amortization
288,000	168,000	162,000	158,000	155,000	141,000	139,000	111,000	104,000	97,000	91,000	87,000	86,000	89,000	78,000	76,000	35,000	29,000	29,000	26,000	27,000	24,000	23,000	22,000	20,000	16,780	17,292	17,237	15,691	16,108	16,626	16,653	16,613	15,272	14,488	14,242	14,325	13,380	13,702	12,391	12,527
Stock compensation expense
117,000	71,000	34,000	34,000	38,000	40,000	38,000	34,000	33,000	36,000	37,000	30,000	32,000	36,000	29,000	32,000	51,000	23,000	15,000	17,000	16,000	13,000	12,000	12,000	11,000	9,748	10,297	8,580	8,375	6,583	6,424	5,618	6,375	4,908	4,424	4,445	4,394	3,650	3,336	3,428	3,460
Impairment
72,000	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gain on contingent consideration
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-1,000	-7,000	-27,000	0	-10,000	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gain (Loss) on Extinguishment of Debt
-44,000	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gain on sale of investments, net
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	6	2,344	7,534	-3,547
Gain on sale of UHP
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	16,402	-8,201
Deferred income taxes
112,000	130,000	-65,000	-33,000	23,000	-26,000	-107,000	-26,000	30,000	-76,000	26,000	-7,000	-51,000	109,000	-4,000	4,000	-17,000	-3,000	-1,000	-7,000	-6,000	23,000	-54,000	-3,000	-8,000	-3,626	-9,089	9,729	986	5,318	-28,682	3,509	5,855	2,254	3,306	-2,829	-700	3,305	2,084	3,978	950
Gain on divestiture
93,000	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other adjustments, net
-24,000	-	-	-	11,000	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Changes in assets and liabilities
Premium and trade receivables
2,182,000	757,000	553,000	-896,000	662,000	477,000	143,000	377,000	176,000	-699,000	53,000	755,000	-59,000	-980,000	-215,000	947,000	174,000	0	19,000	7,000	334,000	220,000	82,000	42,000	119,000	84,413	-12,643	14,496	56,734	-22,414	-93,331	111,961	120,784	-2,000	-2,840	20,362	-4,216	-44,766	10,407	62,175	-4,457
Other assets
-97,000	220,000	-33,000	67,000	-20,000	103,000	-63,000	49,000	-51,000	107,000	104,000	24,000	-89,000	-160,000	-43,000	-10,000	46,000	-	-	25,000	3,000	-18,000	54,000	-26,000	-3,000	60,867	-16,746	-14,658	50,537	13,513	-10,618	23,382	10,723	5,145	2,666	2,365	1,636	308	3,880	427	-1,375
Other assets
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	22,000	15,000	14,000	-64,397	27,206	38,196	-5	-1,082	-398	-996	-524	-1,228	352	1,029	-151	1,038	-729	-218	1,937
Medical claims liabilities
252,000	-513,000	533,000	10,000	548,000	-55,000	663,000	232,000	485,000	-47,000	163,000	-115,000	358,000	130,000	-173,000	-8,000	196,000	142,000	28,000	139,000	227,000	133,000	192,000	88,000	196,000	68,105	-7,730	-5,760	117,385	-14,046	122,996	150,281	100,769	109,280	15,792	11,254	13,430	-1,117	-436	4,261	-33,129
Unearned revenue
-88,000	1,000	128,000	-116,000	-22,000	98,000	-352,000	-115,000	317,000	-236,000	14,000	-79,000	320,000	-258,000	351,000	14,000	-64,000	77,000	-2,000	-51,000	-51,000	75,000	72,000	-53,000	35,000	-4,976	20,044	-15,646	3,578	-97,077	102,192	11,309	8,576	-43,899	-52,718	-22,571	10,106	64,408	47,242	-12,668	-73,282
Accounts payable and accrued expenses
704,000	131,000	64,000	-973,000	357,000	-568,000	900,000	-1,022,000	157,000	-152,000	462,000	-20,000	-237,000	303,000	107,000	-43,000	35,000	-170,000	43,000	108,000	58,000	79,000	267,000	69,000	91,000	103,160	50,328	21,257	-22,745	37,872	17,138	-16,184	-60,826	50,303	23,325	-61,007	26,268	40,572	362	-43,969	40,433
Other long-term liabilities
361,000	117,000	-801,000	522,000	347,000	59,000	-666,000	388,000	477,000	23,000	-736,000	322,000	459,000	-217,000	-307,000	271,000	192,000	-50,000	-43,000	76,000	68,000	72,000	7,000	6,000	4,000	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other operating activities, net
6,000	-11,000	-1,000	-17,000	4,000	16,000	-3,000	-1,000	30,000	-10,000	-4,000	3,000	1,000	8,000	-5,000	2,000	4,000	38,000	-8,000	-14,000	-11,000	-3,000	2,000	1,000	1,000	-1,142	-1,508	1,572	4,078	2,196	-6,274	-3,844	-1,078	6,345	80	2,834	614	694	-3,118	-83	1,934
Net cash (used in) provided by operating activities
-240,000	-651,000	-99,000	917,000	1,316,000	-634,000	548,000	-526,000	1,846,000	450,000	97,000	-306,000	1,248,000	1,592,000	482,000	-419,000	196,000	201,000	62,000	350,000	45,000	370,000	441,000	160,000	252,000	170,330	130,731	37,946	42,993	-28,282	317,182	22,196	-32,096	172,023	36,519	-40,837	93,991	194,625	72,563	-59,756	-38,500
Cash flows from investing activities:
Capital expenditures
177,000	200,000	194,000	160,000	176,000	186,000	127,000	144,000	218,000	121,000	120,000	98,000	83,000	95,000	117,000	49,000	45,000	49,000	43,000	31,000	27,000	34,000	27,000	24,000	18,000	21,617	16,326	19,403	10,654	11,399	13,159	42,462	14,980	16,770	21,810	18,246	16,882	68,203	19,176	18,657	12,520
Capital expenditures of Centene Center LLC
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	74,032	-21,846	-10,579
Purchases of investments
1,400,000	501,000	794,000	700,000	580,000	1,155,000	1,316,000	610,000	765,000	963,000	376,000	735,000	582,000	904,000	572,000	744,000	212,000	244,000	564,000	206,000	307,000	277,000	263,000	308,000	167,000	123,984	128,426	179,459	358,131	194,042	95,057	151,689	255,212	117,252	97,906	62,816	40,423	232,776	76,606	159,189	146,935
Sales and maturities of investments
902,000	562,000	528,000	336,000	383,000	416,000	854,000	276,000	445,000	554,000	293,000	672,000	343,000	611,000	362,000	390,000	203,000	251,000	142,000	165,000	111,000	86,000	99,000	109,000	112,000	127,966	92,063	146,463	212,508	155,991	180,290	104,378	149,341	87,280	59,676	75,121	45,327	118,295	160,393	174,266	117,469
Proceeds from asset sale
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	13,420
Acquisitions, net of cash acquired
3,048,000	5,000	-1,000	32,000	0	97,000	1,721,000	11,000	226,000	50,000	0	0	0	449,000	-14,000	80,000	782,000	2,000	5,000	2,000	9,000	42,000	0	17,000	77,000	227	-4,059	66,832	0	-	-	-	-	-	-	-	-	33,541	5,374	19,454	2,019
Divestiture proceeds, net of divested cash
456,000	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other investing activities, net
5,000	-	-	-	0	-	-	-	-	-	-	0	1,000	-	-	0	0	0	0	0	-7,000	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net cash used in investing activities
-3,272,000	-144,000	-459,000	-556,000	-373,000	-1,022,000	-2,310,000	-489,000	-764,000	-568,000	-202,000	-161,000	-323,000	-837,000	-313,000	-483,000	-836,000	-44,000	-470,000	-74,000	-225,000	-267,000	-191,000	-240,000	-150,000	-17,862	-48,630	-119,231	-156,277	-49,450	72,074	-89,773	-120,851	-47,925	-60,040	-9,133	-11,978	-174,618	50,055	-44,880	-41,164
Cash flows from financing activities:
Proceeds from exercise of stock options
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	2,000	2,000	2,000	1,326	3,807	2,459	1,408	4,314	1,366	1,241	9,079	2,233	1,318	5,746	6,518	1,025	635	1,240	519
Proceeds from long-term debt
2,542,000	12,265,000	6,839,000	4,599,000	1,018,000	597,000	334,000	3,131,000	2,015,000	230,000	360,000	250,000	560,000	1,990,000	1,245,000	1,921,000	3,790,000	620,000	555,000	250,000	500,000	490,000	240,000	500,000	645,000	150,000	0	30,000	0	-	-	-	-	0	0	291,883	127,300	164,726	11,651	20,131	22,030
Proceeds from stock offering
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-23	104,557
Payments of long-term debt
1,039,000	5,510,000	6,940,000	4,426,000	927,000	391,000	221,000	1,980,000	1,491,000	229,000	362,000	202,000	560,000	1,819,000	1,133,000	1,736,000	1,388,000	673,000	431,000	226,000	253,000	556,000	173,000	426,000	519,000	158	30,724	9,342	776	40,578	155,821	20,806	795	808	780	262,118	152,577	98,261	274	57	97,136
Excess tax benefits from stock compensation
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	6,000	1,000	0	4,860	27	598	515	4,951	239	338	5,472	2,803	263	237	1,132	539	129	199	96
Common stock repurchases
558,000	34,000	4,000	2,000	35,000	54,000	4,000	4,000	9,000	47,000	3,000	2,000	13,000	34,000	2,000	5,000	22,000	44,000	2,000	3,000	4,000	23,000	1,000	3,000	2,000	13,323	4,572	540	565	10,846	363	282	1,509	6,529	251	627	402	2,510	146	88	480
Purchase of noncontrolling interest
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Payments for debt extinguishment
21,000	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Contribution from noncontrolling interest
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	5,000	2,136	1,944	3,718	202	-32	50	982	0	-	-	-	-	0	-2,547	-8,425	3,585
Debt issuance costs
92,000	-	-	-	0	-	-	-	-	-	-	-	-	17,000	0	8,000	51,000	0	0	0	4,000	1,000	0	6,000	0	413	0	2,926	661	4,000	0	0	0	0	147	2,990	6,105	-	-	-	0
Other financing activities, net
7,000	4,000	3,000	7,000	2,000	11,000	-1,000	1,000	-2,000	3,000	-4,000	3,000	3,000	3,000	6,000	4,000	-13,000	35,000	-16,000	4,000	-3,000	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Payment of contingent consideration obligation
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net cash provided by financing activities
839,000	6,704,000	-108,000	178,000	58,000	152,000	82,000	3,865,000	513,000	-79,000	-42,000	49,000	-10,000	123,000	102,000	176,000	2,316,000	-62,000	106,000	25,000	236,000	-75,000	74,000	68,000	131,000	144,203	-29,532	39,206	123	124,809	-14,529	56,473	12,247	-2,057	728	32,375	-24,134	16,493	9,448	20,147	26,001
Effect of exchange rate changes on cash, cash equivalents, and restricted cash
-1,000	-6,000	2,000	2,000	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net increase (decrease)
-2,674,000	5,903,000	-664,000	541,000	1,001,000	-1,504,000	-1,680,000	2,850,000	1,595,000	-198,000	-146,000	-418,000	915,000	876,000	272,000	-726,000	1,676,000	95,000	-302,000	301,000	56,000	27,000	324,000	-12,000	233,000	296,671	52,569	-42,079	-113,161	47,077	374,727	-11,104	-140,700	122,041	-22,793	-17,595	57,879	36,500	132,066	-84,489	-53,663
Supplemental disclosures of cash flow information:
Interest paid
104,000	161,000	81,000	45,000	87,000	110,000	83,000	57,000	73,000	27,000	111,000	27,000	72,000	52,000	77,000	33,000	3,000	27,000	1,000	25,000	2,000	22,000	2,000	14,000	2,000	13,262	1,568	13,760	1,410	9,873	1,815	8,723	1,589	11,286	4,275	10,108	1,714	7,795	2,181	6,975	345
Income taxes paid
3,000	101,000	130,000	375,000	6,000	108,000	145,000	194,000	1,000	138,000	153,000	203,000	2,000	162,000	172,000	189,000	33,000	99,000	84,000	121,000	24,000	70,000	57,000	89,000	21,000	44,079	19,227	19,489	2,205	8,999	1,607	11,880	20,514	448	9,885	30,544	9,567	9,531	16,467	19,668	8,272
Equity issued in connection with acquisitions
11,526,000	0	0	0	0	0	0	183,000	324,000	0	0	0	0	0	0	0	3,105,000	0	-1,000	0	13,000	0	58,000	0	132,000	-425	-13	75,438	0	-	-	-	-	-	-	-	-	-	-	-	-
The following table provides a reconciliation of cash, cash equivalents, and restricted cash and cash equivalents reported within the Consolidated Balance Sheets to the totals above:
Contribution from noncontrolling interest
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	306
Capital expenditures
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1,477	-	-20,989	35,491	789